The next-gen chipmaker first filed for its IPO in September 2024. Now, after snags that held up its debut, it’s a public company.
The government argues it needs user data to prosecute EZ Lynk for allegedly willfully helping users break emissions laws (which the company denies). But it looks like unnecessary overreach.
How Scale AI Is Adapting Post Meta Deal And Founder’s Departure
The initial public offerings for SpaceX, OpenAI and Anthropic are on track to surpass the cash VCs raked in on every other startup exit since 2016—combined.
Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it might bring to the clinic.
In this week’s edition of InnovationRx, we look at the latest on the hantavirus outbreak, using quantum physics for metabolic MRIs, how AI can help fill prescriptions and more.
NVision raises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next up: using its quantum technology to design new drugs.
HR leaders aren’t just reviewing your resume—they’re searching your name online. Here’s what they’re looking for to ensure you’re a real person fit for the role.
Startup Depthfirst claims its AI found some major flaws in tools that help run much of the internet, all for a tenth of the cost of Anthropic’s comparable model Mythos.
Forus reached $1 billion valuation by dealing with the unglamorous admin work of processing scrips so patients can get the drugs they need.